NEW YORK ( TheStreet) -- China Medical Technologies (Nasdaq: CMED) hit a new 52-week low Wednesday as it is currently trading at $6.32, below its previous 52-week low of $6.34 with 79,251 shares traded as of 10:53 a.m. ET. Average volume has been 373,100 shares over the past 30 days.

China Medical has a market cap of $213.6 million and is part of the health care sector and health services industry. Shares are down 41.7% year to date as of the close of trading on Tuesday.

China Medical Technologies, Inc., a medical device company, develops, manufactures, and markets advanced immunodiagnostic and molecular diagnostic products primarily in the People's Republic of China. The company has a P/E ratio of 4.2, below the average health services industry P/E ratio of 14 and below the S&P 500 P/E ratio of 17.7.
  • Practice your CMED trading strategies and win cash in our stock game.

TheStreet Ratings rates China Medical as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, impressive record of earnings per share growth and compelling growth in net income. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself and generally poor debt management. You can view the full China Medical Ratings Report.

See all 52-week low stocks or get investment ideas from our investment research center.